Quick Answer
SINOVAC BIOTECH LTD reported Stockholders Equity of $8.71 billion for the year ending 2023.
- SINOVAC BIOTECH LTD showed a decrease of -2.4% in Stockholders Equity from 2022 to 2023.
- This data is from SINOVAC BIOTECH LTD's annual report (Form 10-K), filed with the SEC on April 29, 2024.
- XBRL data for this metric is available from 2010 to 2023 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 14 years of available data (2010 to 2023), SINOVAC BIOTECH LTD's Stockholders Equity has grown by 6,788.2%.
- Historical annual values: Fiscal year 2023: $8.71 billion | Fiscal year 2022: $8.92 billion | Fiscal year 2021: $9.33 billion | Fiscal year 2020: $746.47 million | Fiscal year 2019: $294.02 million | Fiscal year 2018: $253.43 million | Fiscal year 2017: $151.15 million | Fiscal year 2016: $115.77 million | Fiscal year 2015: $121.65 million | Fiscal year 2014: $126.56 million | Fiscal year 2013: $128.68 million | Fiscal year 2012: $117.72 million | Fiscal year 2011: $129.92 million | Fiscal year 2010: $126.44 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: